Literature DB >> 32386948

18FDG PET/CT Scan Reveals Hypoactive Orbitofrontal Cortex in Anosmia of COVID-19.

Mahboobeh Karimi-Galougahi1, Abbas Yousefi-Koma1, Mehrdad Bakhshayeshkaram1, Nasim Raad1, Sara Haseli2.   

Abstract

Entities:  

Year:  2020        PMID: 32386948      PMCID: PMC7196385          DOI: 10.1016/j.acra.2020.04.030

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


× No keyword cloud information.
Dear Editor During the current nascent pandemic, anosmia has been increasingly reported among patients with coronavirus disease-2019 (COVID-19) (1). While postviral olfactory loss secondary to nasal congestion or conductive pathway alteration is a known sequela of sinonasal viral infections (2), anosmia of COVID-19 is less commonly associated with rhinorrhea or nasal congestion (3). This may indicate sensory neural loss as the underlying cause of the olfactory dysfunction rather than the conductive mechanism in most cases of postviral olfactory loss. We have recently reported normal morphology of the olfactory bulb on magnetic resonance imaging in anosmia of COVID-19 (4). Whether there is decreased neural activity in olfactory pathways despite normal morphology is unknown. We sought to assess the neural metabolic activity in anosmia of COVID-19 by 18fluoro-2-deoxy-d-glucose (18FDG) positron emission tomography–computed tomography (PET-CT). We included a 27-year-old healthy, right-handed woman, diagnosed with COVID-19 by polymerase chain reaction assay. The patient had persistent isolated anosmia for 6 weeks. She had no history of alcohol intake or tobacco smoking and no background of psychiatric problems. The patient was asked to fast for 6 hours prior to imaging. We performed 18FDG-PET/CT in a neutral environment using 5 ml of aerosolized 0.9% NaCl delivered with O2 at 3.5 ml/min via facial mask for 9 minutes. The patient was instructed to breath normally without sniffing. After 3 minutes, the patient received intravenous 18FDG (4.6 Megabecquerel/kg, Masih Daneshvari Hospital, Tehran), and the neutral olfactory condition continued for another 6 minutes. The patient laid down in a semi-darkened, noiseless, and odorless room, with her eyes closed. After an uptake time of 60 minutes, the brain and whole-body PET/CT scan was performed with sequential TOF-PET/CT (Discovery 690 PET/CT with 64 slices, GE Healthcare, USA). The PET tomography consisted of LYSO (Lu1.8Y0.2 SiO5 (Ce)) crystals with dimensions of 4.2 × 6.3 × 25 mm3. Data was acquired in 3D mode with scan duration of 10 minutes for the brain scan and 2 minutes per bed position for the whole-body scan. The images were reviewed by a nuclear medicine physician and a radiologist with substantial experience in PET/CT reporting in consensus. The PET-CT images suggested hypometabolism of the left orbitofrontal cortex (Fig 1 ). The standardized uptake value (SUV) of 9.5 on the left side was reduced compared with the SUV of 10 on the right side. Our finding is in contrast to higher metabolic activity of the left orbitofrontal cortex compared with the right side in right-handed subjects with normal olfaction (5). The FDG uptake in the left inferior temporal cortex was normal (Fig 1).
Figure. 1

18FDG-PET/CT scan of a 27-year-old woman with persistent anosmia and positive PCR for SARS-CoV-2. Representative axial (A, B, D) and coronal (C) images are shown. There was decreased uptake in the left orbitofrontal cortex (arrows). The uptake of temporal lobes were symmetric and normal (arrows, D).

18FDG-PET/CT scan of a 27-year-old woman with persistent anosmia and positive PCR for SARS-CoV-2. Representative axial (A, B, D) and coronal (C) images are shown. There was decreased uptake in the left orbitofrontal cortex (arrows). The uptake of temporal lobes were symmetric and normal (arrows, D). Olfactory perception is a sophisticated chemosensory process involving different parts of the cerebral cortices, mainly orbitofrontal and limbic system. Peripherally located olfactory dendrites within receptor cells that connect to the central nervous system (ie, olfactory bulb) may provide a route for neuro-invasion in SARS-CoV-2-induced anosmia (6). There are two separate subsystems for smelling and sniffing resulting in stimulation of different cerebral cortices, and therefore, asymmetric cortical activity. Under olfactory condition (using a pure odor), Cuneus, lingual gyrus, and parahipocampal gyrus have higher glucose metabolic activity mainly in the left hemisphere in right-handed subjects (7, 8, 9). In contrast, under neutral condition (normal saline used in our study), superior, middle, inferior, medial frontal, and orbital gyrus (ie, orbitofrontal cortex) as well as anterior cingulate gyrus have higher metabolic activity on the left-side compared to the right-side in right-handed subjects. Orbitofrontal cortex is responsible for detection of common odors and on FDG-PET-CT has a lower uptake under olfactory condition than under neutral condition (5). The present study examined the FDG uptake patterns under neutral condition. To elucidate the full spectrum of olfactory abnormalities in anosmia of COVID-19, it is necessary to perform 18FDG-PET-CT under olfactory condition in future studies. In conclusion, to the best of our knowledge, this is the first report of reduced metabolic activity in the orbitofrontal cortex in anosmia of COVID-19, suggesting impaired neural function in this region as an underlying cause of anosmia, likely due to direct neurotropism of SARS-CoV-2.
  8 in total

1.  Recurrent cortical circuits implement concentration-invariant odor coding.

Authors:  Kevin A Bolding; Kevin M Franks
Journal:  Science       Date:  2018-09-14       Impact factor: 47.728

2.  Activity in the rat olfactory cortex is correlated with behavioral response to odor: a microPET study.

Authors:  Philippe Litaudon; Caroline Bouillot; Luc Zimmer; Nicolas Costes; Nadine Ravel
Journal:  Brain Struct Funct       Date:  2016-05-18       Impact factor: 3.270

3.  Cortical metabolic arrangement during olfactory processing: proposal for a 18F FDG PET/CT methodological approach.

Authors:  Alessandro Micarelli; Marco Pagani; Agostino Chiaravalloti; Ernesto Bruno; Isabella Pavone; Matteo Candidi; Roberta Danieli; Orazio Schillaci; Marco Alessandrini
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

4.  Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.

Authors:  Jerome R Lechien; Carlos M Chiesa-Estomba; Daniele R De Siati; Mihaela Horoi; Serge D Le Bon; Alexandra Rodriguez; Didier Dequanter; Serge Blecic; Fahd El Afia; Lea Distinguin; Younes Chekkoury-Idrissi; Stéphane Hans; Irene Lopez Delgado; Christian Calvo-Henriquez; Philippe Lavigne; Chiara Falanga; Maria Rosaria Barillari; Giovanni Cammaroto; Mohamad Khalife; Pierre Leich; Christel Souchay; Camelia Rossi; Fabrice Journe; Julien Hsieh; Myriam Edjlali; Robert Carlier; Laurence Ris; Andrea Lovato; Cosimo De Filippis; Frederique Coppee; Nicolas Fakhry; Tareck Ayad; Sven Saussez
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-04-06       Impact factor: 2.503

5.  Cortico-subcortical metabolic correlates of olfactory processing in healthy resting subjects.

Authors:  Marco Alessandrini; Alessandro Micarelli; Agostino Chiaravalloti; Matteo Candidi; Ernesto Bruno; Barbara Di Pietro; Orazio Schillaci; Marco Pagani
Journal:  Sci Rep       Date:  2014-06-03       Impact factor: 4.379

Review 6.  A lifetime of neurogenesis in the olfactory system.

Authors:  Jessica H Brann; Stuart J Firestein
Journal:  Front Neurosci       Date:  2014-06-26       Impact factor: 4.677

7.  Olfactory Bulb Magnetic Resonance Imaging in SARS-CoV-2-Induced Anosmia: The First Report.

Authors:  Mahboobeh Karimi Galougahi; Jahangir Ghorbani; Mehrdad Bakhshayeshkaram; Ali Safavi Naeini; Sara Haseli
Journal:  Acad Radiol       Date:  2020-04-11       Impact factor: 3.173

8.  Anosmia and Ageusia: Common Findings in COVID-19 Patients.

Authors:  Luigi A Vaira; Giovanni Salzano; Giovanna Deiana; Giacomo De Riu
Journal:  Laryngoscope       Date:  2020-04-15       Impact factor: 3.325

  8 in total
  37 in total

Review 1.  FDG-PET/CT images of COVID-19: a comprehensive review.

Authors:  Ryogo Minamimoto; Masatoshi Hotta; Masahiro Ishikane; Takeshi Inagaki
Journal:  Glob Health Med       Date:  2020-08-31

2.  Anosmia in COVID-19 Associated with Injury to the Olfactory Bulbs Evident on MRI.

Authors:  M F V V Aragão; M C Leal; O Q Cartaxo Filho; T M Fonseca; M M Valença
Journal:  AJNR Am J Neuroradiol       Date:  2020-06-25       Impact factor: 3.825

Review 3.  Critical neurological features of COVID-19: Role of imaging methods and biosensors for effective diagnosis.

Authors:  Vishakha Singh; Prince Allawadhi; Amit Khurana; Anil Kumar Banothu; Kala Kumar Bharani
Journal:  Sens Int       Date:  2021-05-13

4.  Quantitative Analysis of the Olfactory System in COVID-19: An MR Imaging Study.

Authors:  E Altunisik; A H Baykan; S Sahin; E Aydin; S M Erturk
Journal:  AJNR Am J Neuroradiol       Date:  2021-09-23       Impact factor: 3.825

5.  [18F-FDG-PET/CT in SARS-CoV-2 infection and its sequelae].

Authors:  B Rodríguez-Alfonso; S Ruiz Solís; L Silva-Hernández; I Pintos Pascual; S Aguado Ibáñez; C Salas Antón
Journal:  Rev Esp Med Nucl Imagen Mol       Date:  2021-07-12       Impact factor: 1.359

6.  Olfactory Training in Post-COVID-19 Persistent Olfactory Disorders: Value Normalization for Threshold but Not Identification.

Authors:  Clair Vandersteen; Magali Payne; Louise-Émilie Dumas; Élisa Cancian; Alexandra Plonka; Grégoire D'Andréa; David Chirio; Élisa Demonchy; Karine Risso; Florence Askenazy-Gittard; Charles Savoldelli; Nicolas Guevara; Philippe Robert; Laurent Castillo; Valeria Manera; Auriane Gros
Journal:  J Clin Med       Date:  2022-06-08       Impact factor: 4.964

7.  Parosmia Due to COVID-19 Disease: A 268 Case Series.

Authors:  Rasheed Ali Rashid; Ameer A Alaqeedy; Raid M Al-Ani
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-05-23

8.  Molecular Imaging Findings on Acute and Long-Term Effects of COVID-19 on the Brain: A Systematic Review.

Authors:  Philipp T Meyer; Sabine Hellwig; Ganna Blazhenets; Jonas A Hosp
Journal:  J Nucl Med       Date:  2022-02-17       Impact factor: 11.082

9.  COVID-19 and the brain: impact on nuclear medicine in neurology.

Authors:  Silvia Morbelli; Ozgul Ekmekcioglu; Henryk Barthel; Nathalie L Albert; Ronald Boellaard; Diego Cecchin; Eric Guedj; Adriaan A Lammertsma; Ian Law; Ivan Penuelas; Franck Semah; Tatjana Traub-Weidinger; Elsmarieke van de Giessen; Andrea Varrone; Valentina Garibotto
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-10       Impact factor: 9.236

10.  Orbitofrontal involvement in a neuroCOVID-19 patient.

Authors:  Loïc Le Guennec; Julia Devianne; Laurence Jalin; Albert Cao; Damien Galanaud; Vincent Navarro; David Boutolleau; Benjamin Rohaut; Nicolas Weiss; Sophie Demeret
Journal:  Epilepsia       Date:  2020-07-23       Impact factor: 6.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.